Nuvectis Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BALDWIN BROTHERS LLC/MA | 01/22/2025 | 355,961 | $1.93 M | 104.42% | 2.07% |
| VANGUARD GROUP INC | 02/11/2025 | 325,297 | $1.76 M | 8.02% | 1.89% |
| MARSHALL WACE, LLP | 02/13/2025 | 124,571 | $673,929 | 190.96% | 0.72% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 79,243 | $428,777 | -0.59% | 0.46% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 62,342 | $337,270 | 25.81% | 0.36% |
| FORBES J M & CO LLP | 01/28/2025 | 59,000 | $319,190 | 21.90% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 45,607 | $246,734 | 72.34% | 0.26% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 34,751 | $188,000 | -30.68% | 0.20% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 30,594 | $165,514 | 36.38% | 0.18% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 29,698 | $160,666 | -56.64% | 0.17% |
| OPPENHEIMER & CO INC | 02/05/2025 | 25,000 | $135,250 | 100.00% | 0.15% |
| SQUAREPOINT OPS LLC | 02/14/2025 | 19,071 | $103,174 | 100.00% | 0.11% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 18,570 | $100,464 | -30.67% | 0.11% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 02/12/2025 | 15,170 | $82,070 | -20.87% | 0.09% |
| BAXTER BROS INC | 02/12/2025 | 15,000 | $81,150 | 20.00% | 0.09% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 01/30/2025 | 13,500 | $73,035 | 35.00% | 0.08% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 6,294 | $34,051 | 100.00% | 0.04% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 02/14/2025 | 4,479 | $24,231 | 100.00% | 0.03% |
| UBS GROUP AG | 02/14/2025 | 2,669 | $14,440 | 24,163.64% | 0.02% |
| BARCLAYS PLC | 02/13/2025 | 1,144 | $6,000 | 0.00% | 0.01% |
| HOLLENCREST CAPITAL MANAGEMENT | 02/10/2025 | 400 | $2,164 | 42.86% | 0.00% |
| 01/23/2025 | 310 | $1,677 | 100.00% | 0.00% | |
| JPMORGAN CHASE & CO | 02/12/2025 | 179 | $968 | -6.77% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 115 | $622 | 100.00% | 0.00% |
| STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 02/06/2025 | 100 | $541 | 0.00% | 0.00% |
| POINT72 (DIFC) LTD | 02/14/2025 | 49 | $265 | 100.00% | 0.00% |
| NBC SECURITIES, INC. | 01/22/2025 | 5 | $27 | -98.33% | 0.00% |
| FMR LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| CITIGROUP INC | 02/12/2025 | 0 | $0 | -100.00% | 0.00% |
| NISA INVESTMENT ADVISORS, LLC | 01/17/2025 | 0 | $0 | -100.00% | 0.00% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 01/28/2025 | 0 | $0 | -100.00% | 0.00% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 0 | $0 | -100.00% | 0.00% |
| 02/10/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Nuvectis Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 38 institutional investors and hedge funds held shares of Nuvectis Pharma, Inc.. The most heavily invested institutionals were:
BALDWIN BROTHERS LLC/MA: 355,961
VANGUARD GROUP INC: 325,297
MARSHALL WACE, LLP: 124,571
GEODE CAPITAL MANAGEMENT, LLC: 79,243
BlackRock Funding, Inc. /DE: 62,342
FORBES J M & CO LLP: 59,000
7.67% of Nuvectis Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.93 M shares in the last 24 months. This purchase volume represents approximately $12.78 M in transactions.